BioSpace News Archive

Biotech Beach

GenFleet Therapeutics Announces Broad-spectrum Activity of GFH547 in Late-breaking Research Abstract of 2024 AACR Annual Meeting

GenFleet Therapeutics today announced the latest findings of GFH547, an oral panRAS (ON) inhibitor, in a late-breaking research abstract at the 2024 American Association for Cancer Research (AACR) Annual Meeting.

April 9, 2024
·
4 min read
EFISHient Protein Announces Successful Development of Tilapia Cell Line

EFISHient Protein, a leading Israeli FoodTech company, proudly announces the successful completion of the Tilapia cell line development.

April 9, 2024
·
2 min read
Drug Development

Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia

Alkermes plc (Nasdaq: ALKS) today announced positive topline results from the narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH) cohorts of a phase 1b, proof-of-concept study evaluating ALKS 2680, the company’s novel, investigational, oral orexin 2 receptor (OX2R) agonist in development as a once-daily treatment for narcolepsy.

April 9, 2024
·
10 min read
Business

Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024

Numinus Wellness Inc. will release its financial results for the quarter ended February 29, 2024.

April 9, 2024
·
2 min read
Biotech Bay

CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting

CareDx, Inc. today announced that CareDx and study collaborators will be presenting the latest data featuring CareDx’s cardiothoracic portfolio at the International Society for Heart and Lung Transplantation (ISHLT) 44th Annual Meeting & Scientific Sessions, taking place from April 10-13 in Prague, Czech Republic.

April 9, 2024
·
5 min read
Drug Development

Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT

Seres Therapeutics, Inc. announced today that enrollment is complete in the placebo-controlled Cohort 2 of its Phase 1b trial of SER-155 in patients who received Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT).

April 9, 2024
·
5 min read
Genetown

Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum

Deciphera Pharmaceuticals, Inc. today announced that members of the management team will participate in a fireside chat at the Stifel 2024 Virtual Targeted Oncology Forum on Tuesday, April 16, 2024 at 11:30 AM ET.

April 9, 2024
·
1 min read
Business

NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024

NeoGenomics, Inc. today announced that it will report its first quarter 2024 financial results on Tuesday, April 30, 2024.

April 9, 2024
·
1 min read
Policy

Antibe to File an Application for an Initial Order Under Companies’ Creditors Arrangement Act

Antibe Therapeutics Inc. (“ Antibe ” or the “ Company ”) (TSX: ATE, OTCQX: ATBPF) announced that it intends to file an application today with the Ontario Superior Court of Justice (Commercial List) (the " Court ") for an Initial Order under the Companies’ Creditors Arrangement Act (the " CCAA ").

April 9, 2024
·
3 min read
Calliditas Therapeutics to Attend Conferences in April

Calliditas Therapeutics AB today announced that its management will be attending the following upcoming investor and industry conferences.

April 9, 2024
·
1 min read